| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Valeria Giorgi, Daniela Marotto, Alberto Batticciotto, Fabiola Atzeni, Sara Bongiovanni, Piercarlo Sarzi-Puttin. Cannabis and Autoimmunity: Possible Mechanisms of Action. ImmunoTargets and therapy. vol 10. 2021-07-30. PMID:34322454. |
in this review, we summarized the main mechanisms of action of medical cannabis plant especially regarding the immune system and the endocannabinoid system, looking at preliminary clinical data in three most important autoimmune diseases of three different specialities: rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. |
2021-07-30 |
2023-08-13 |
human |
| Mahmoud Abu-Amna, Talal Salti, Mona Khoury, Idan Cohen, Gil Bar-Sel. Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk? Current treatment options in oncology. vol 22. issue 2. 2021-07-29. PMID:33439370. |
in light of the growing popularity of cannabis usage, it is highly essential that, in the near future, the medical community will be able to provide practical recommendations and explicit guidelines, including doses, and that cannabinoid concentrations in the used products are defined regarding its prescription before any medical procedure involving its usage is authorized. |
2021-07-29 |
2023-08-13 |
Not clear |
| Franjo Grotenhermen, Kirsten R Müller-Vah. Two Decades of the International Association for Cannabinoid Medicines: 20 Years of Supporting Research and Activities Toward the Medicinal Use of Cannabis and Cannabinoids. Cannabis and cannabinoid research. vol 6. issue 2. 2021-07-29. PMID:33912675. |
two decades of the international association for cannabinoid medicines: 20 years of supporting research and activities toward the medicinal use of cannabis and cannabinoids. |
2021-07-29 |
2023-08-13 |
Not clear |
| Franjo Grotenhermen, Kirsten R Müller-Vah. Two Decades of the International Association for Cannabinoid Medicines: 20 Years of Supporting Research and Activities Toward the Medicinal Use of Cannabis and Cannabinoids. Cannabis and cannabinoid research. vol 6. issue 2. 2021-07-29. PMID:33912675. |
emerged from the german association for cannabis as medicine (acm), a handful of enthusiastic medical doctors from germany, switzerland, and austria supported by experts from other countries established the international association for cannabinoid medicines (iacm) in march 2000. |
2021-07-29 |
2023-08-13 |
Not clear |
| Franjo Grotenhermen, Kirsten R Müller-Vah. Two Decades of the International Association for Cannabinoid Medicines: 20 Years of Supporting Research and Activities Toward the Medicinal Use of Cannabis and Cannabinoids. Cannabis and cannabinoid research. vol 6. issue 2. 2021-07-29. PMID:33912675. |
the overarching aim of the iacm is to advance the knowledge on cannabis, cannabinoids, the endocannabinoid system, and related topics especially with regard to their therapeutic potential, which would allow more patients to profit from a treatment with cannabis-based medicines and ease legislators to adopt their policies. |
2021-07-29 |
2023-08-13 |
Not clear |
| Meagan Petersen, Katherine Koller, Craig Straley, Ellen Ree. Effect of cannabis use on PTSD treatment outcomes in veterans. The mental health clinician. vol 11. issue 4. 2021-07-29. PMID:34316419. |
some theorize cannabinoids such as those in cannabis may provide a new treatment approach for ptsd, while others suggest it may worsen symptomology. |
2021-07-29 |
2023-08-13 |
Not clear |
| Cinzia Citti, Pasquale Linciano, Giuseppe Cannazz. Is cannabidiol a scheduled controlled substance? Origin makes the difference. Drug discovery today. vol 25. issue 4. 2021-07-28. PMID:32062008. |
cannabidiol (cbd) is the main cannabinoid naturally occurring in hemp. |
2021-07-28 |
2023-08-13 |
Not clear |
| Cesar D Lopez, Venkat Boddapati, Charles M Jobin, Thomas R Hickernel. State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort. The Journal of the American Academy of Orthopaedic Surgeons. vol 29. issue 4. 2021-07-28. PMID:32404683. |
cannabinoids offer a potentially attractive nonopioid analgesic option for orthopaedic patients, and 32 us states have passed medical cannabis laws (mcls), legalizing patient access to cannabinoids. |
2021-07-28 |
2023-08-13 |
Not clear |
| Iain S McGregor, Elizabeth A Cairns, Sarah Abelev, Rhys Cohen, Mat Henderson, Daniel Couch, Jonathon C Arnold, Natalie Gaul. Access to cannabidiol without a prescription: A cross-country comparison and analysis. The International journal on drug policy. vol 85. 2021-07-28. PMID:32919298. |
in some locations, this includes over-the-counter (otc) and/or online access to products containing cannabidiol (cbd), a non-intoxicating cannabinoid with therapeutic properties. |
2021-07-28 |
2023-08-13 |
Not clear |
| F M Filbey, D Beaton, S Prasha. The contributions of the endocannabinoid system and stress on the neural processing of reward stimuli. Progress in neuro-psychopharmacology & biological psychiatry. vol 106. 2021-07-27. PMID:33221340. |
we examined the relationship between factors that regulate endocannabinoid system signaling (i.e., cannabinoid receptor genes and prolonged cannabis exposure) and stress on fmri bold response to reward cues using multivariate statistical analysis. |
2021-07-27 |
2023-08-13 |
Not clear |
| F M Filbey, D Beaton, S Prasha. The contributions of the endocannabinoid system and stress on the neural processing of reward stimuli. Progress in neuro-psychopharmacology & biological psychiatry. vol 106. 2021-07-27. PMID:33221340. |
we found that proxies for endocannabinoid system signaling (i.e., endocannabinoid genes and chronic exposure to cannabis) and stress have differential effects on neural response to cannabis cues. |
2021-07-27 |
2023-08-13 |
Not clear |
| F M Filbey, D Beaton, S Prasha. The contributions of the endocannabinoid system and stress on the neural processing of reward stimuli. Progress in neuro-psychopharmacology & biological psychiatry. vol 106. 2021-07-27. PMID:33221340. |
understanding the contributions of endocannabinoid system factors and stress that lead to downstream effects on neural mechanisms underlying sensitivity to rewards, such as cannabis, will contribute towards a better understanding of endocannabinoid-targeted therapies as well as individual risks for cannabis use disorder. |
2021-07-27 |
2023-08-13 |
Not clear |
| Dorina V Pinkhasova, Laura E Jameson, Kendra D Conrow, Michael P Simeone, Allan Peter Davis, Thomas C Wiegers, Carolyn J Mattingly, Maxwell C K Leun. Regulatory Status of Pesticide Residues in Cannabis: Implications to Medical Use in Neurological Diseases. Current research in toxicology. vol 2. 2021-07-27. PMID:34308371. |
further research is needed to assess human health risk of cannabinoids and pesticides in support of a national standard for cannabis pesticide regulations. |
2021-07-27 |
2023-08-13 |
human |
| Kurt Leroy Hoffma. From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia. Frontiers in psychiatry. vol 12. 2021-07-23. PMID:34290632. |
the present mini-review focuses on animal models of schizophrenia that have explored the effects of cannabidiol (cbd; a non-psychoactive component of cannabis) or the pharmacological manipulation of the endocannabinoid system on behavioral and cognitive outcome measures. |
2021-07-23 |
2023-08-13 |
Not clear |
| Marta Concheiro, Frank Martin Gutierrez, Alejandro Ocampo, Elena Lendoiro, Eva González-Colmenero, Ana Concheiro-Guisán, Patricia Peñas-Silva, Manuel Macías-Cortiña, Angelines Cruz-Landeira, Manuel López-Rivadulla, Ana de-Castro-Río. Assessment of biological matrices for the detection of in utero cannabis exposure. Drug testing and analysis. vol 13. issue 7. 2021-07-22. PMID:33750017. |
due to the negative effects of prenatal cannabis exposure, it is necessary to develop an objective, sensitive, and specific method to determine cannabinoids use during pregnancy. |
2021-07-22 |
2023-08-13 |
Not clear |
| Howard Meng, Tianyang Dai, John G Hanlon, James Downar, Shabbir M H Alibhai, Hance Clark. Cannabis and cannabinoids in cancer pain management. Current opinion in supportive and palliative care. vol 14. issue 2. 2021-07-21. PMID:32332209. |
cannabis and cannabinoids in cancer pain management. |
2021-07-21 |
2023-08-13 |
Not clear |
| Howard Meng, Tianyang Dai, John G Hanlon, James Downar, Shabbir M H Alibhai, Hance Clark. Cannabis and cannabinoids in cancer pain management. Current opinion in supportive and palliative care. vol 14. issue 2. 2021-07-21. PMID:32332209. |
an increasing number of patients are turning to cannabis and cannabinoids for management of their palliative and nonpalliative cancer pain and other cancer-related symptoms. |
2021-07-21 |
2023-08-13 |
Not clear |
| Howard Meng, Tianyang Dai, John G Hanlon, James Downar, Shabbir M H Alibhai, Hance Clark. Cannabis and cannabinoids in cancer pain management. Current opinion in supportive and palliative care. vol 14. issue 2. 2021-07-21. PMID:32332209. |
this review seeks to delineate the role of cannabis and cannabinoids in cancer pain management and offers insight into the canadian practice. |
2021-07-21 |
2023-08-13 |
Not clear |
| Dan Jin, Philippe Henry, Jacqueline Shan, Jie Che. Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots. Frontiers in plant science. vol 12. 2021-07-20. PMID:34276749. |
hierarchical clustering, principal component analysis (pca), and canonical correlation analysis assigned 21 cannabis varieties into three chemotypes using the content and ratio of cannabinoids, terpenoids, flavonoids, sterols, and triterpenoids across inflorescences, leaves, stem bark, and roots. |
2021-07-20 |
2023-08-13 |
Not clear |
| Grace M Kroner, Kamisha L Johnson-Davis, Kelly Doyle, Gwendolyn A McMilli. Cannabinol (CBN) Cross-Reacts with Two Urine Immunoassays Designed to Detect Tetrahydrocannabinol (THC) Metabolite. The journal of applied laboratory medicine. vol 5. issue 3. 2021-07-19. PMID:32445358. |
the psychoactive component of cannabis, tetrahydrocannabinol (thc), is one of many cannabinoids present in the plant. |
2021-07-19 |
2023-08-13 |
Not clear |